These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 20546897

  • 1. Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.
    Gjerstorff MF, Besir H, Larsen MR, Ditzel HJ.
    Protein Expr Purif; 2010 Oct; 73(2):217-22. PubMed ID: 20546897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression and purification of the cancer antigen SSX2: a potential cancer vaccine.
    Huang CJ, Chen RH, Vannelli T, Lee F, Ritter E, Ritter G, Old LJ, Batt CA.
    Protein Expr Purif; 2007 Dec; 56(2):212-9. PubMed ID: 17931884
    [Abstract] [Full Text] [Related]

  • 4. The potential of melanoma antigen expression in cancer therapy.
    Gillespie AM, Coleman RE.
    Cancer Treat Rev; 1999 Aug; 25(4):219-27. PubMed ID: 10448130
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of GAGE family proteins in malignant melanoma.
    Bazhin AV, Wiedemann N, Schnölzer M, Schadendorf D, Eichmüller SB.
    Cancer Lett; 2007 Jun 28; 251(2):258-67. PubMed ID: 17194529
    [Abstract] [Full Text] [Related]

  • 7. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF, Burns J, Ditzel HJ.
    Expert Opin Biol Ther; 2010 Jul 28; 10(7):1061-75. PubMed ID: 20420535
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
    Dannull J, Diener PA, Prikler L, Fürstenberger G, Cerny T, Schmid U, Ackermann DK, Groettrup M.
    Cancer Res; 2000 Oct 01; 60(19):5522-8. PubMed ID: 11034097
    [Abstract] [Full Text] [Related]

  • 10. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M, Lee J, Milazzo C, Boczkowski D, Su Z, Nair S, Gilboa E.
    Clin Cancer Res; 2005 Aug 01; 11(15):5566-71. PubMed ID: 16061874
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope.
    Kazaks A, Balmaks R, Voronkova T, Ose V, Pumpens P.
    Biotechnol J; 2008 Nov 01; 3(11):1429-36. PubMed ID: 18956370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cancer immunotherapy targeting the telomerase reverse transcriptase.
    Huo LF, Tang JW, Huang JJ, Huang PT, Huang CF, Kung HF, Lin MC.
    Cell Mol Immunol; 2006 Feb 01; 3(1):1-11. PubMed ID: 16549043
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells.
    Zhang Y, Renkvist N, Sun Z, Schuler-Thurner B, Glaichenhaus N, Schuler G, Boon T, van der Bruggen P, Colau D.
    Eur J Immunol; 2005 Apr 01; 35(4):1066-75. PubMed ID: 15756643
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.